Starting in March 2014, Kenneth Drazan, M.D. took over as head of Johnson & Johnson Innovation Centers in California. Drazan is also co-founder and emeritus partner at Bertram Capital Management LLC, where he oversaw healthcare investments at the firm. A board certified and award-winning surgeon, Drazan has been a life science executive and co-founder of several drug discovery companies, including Arginox Pharmaceuticals, EnGen Bio, Cardero, Genesoft Pharmaceuticals and PinPoint Therapeutics. Earlier in his career, Drazan was a leading academic liver transplant surgeon and scientist at Stanford University and UCLA. Drazan received his M.D., cum laude, from the State University of New York and bachelor’s degree in economics, cum laude, from Yale University.